Camille Van Wesemael

Camille Van Wesemael

Auto-generated profile, based on publicly available information

Camille Van Wesemael

Laboratoire d'Innovation Thérapeutique Université de Strasbourg CNRS LIT UMR 7200F Strasbourg 67000 France

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2025 in Chemistry – A European Journal
Verified
Journal Article
Open access
TMTimothé Maujean
Timothé Maujean
CWCamille Van Wesemael
Camille Van Wesemael
LTLaurine Tual
Laurine Tual
VBValentine Le Berruyer
Valentine Le Berruyer
BRBlanca Rodriguez‐Noguer
Blanca Rodriguez‐Noguer
Mihaela GuleaMihaela Gulea
Mihaela Gulea
We report an efficient double‐click strategy combining copper‐catalyzed azide–alkyne cycloaddition (CuAAC) with (thia‐)Diels–Alder (DA) reactions, enabled by newly designed heterobifunctional platforms bearing orthogonal clickable groups: alkyne–dithioester, alkyne–maleimide, or azide–diene. These platforms were evaluated through both one‐pot sequential protocols (CuAAC/DA or CuAAC/thia‐DA) and three‐component reactions (3CR), using model substrates with complementary functionalities. The use of a highly reactive s‐cis‐constrained exocyclic diene, enabled rapid cycloadditions with maleimide or phosphonodithioester dienophiles. All reactions were performed under mild, biocompatible conditions (37 °C, 1:1 H₂O/iPrOH, 1–2 hours), and most afforded the desired conjugates in good isolated yields. The methodology was further validated through the successful bioconjugation of three small peptides with either a fluorophore or biotin, demonstrating its efficiency, versatility, and compatibility with biologically relevant functional groups.